M. Pr?stegaard, B. Vestbjerg, J. Selmer, and T. Holm-Larsen, “Phase 3 Trial Demonstrates Superior Patient Treatment Convenience of MC2-01 Calcipotriene Plus Betamethasone Dipropionate Cream Compared to Current Topical Suspension”, J of Skin, vol. 4, no. 5, p. s62, Sep. 2020.